FDA Launches SAFEKIDS Initiative With Academic And Clinical Partners
The U.S. Food and Drug Administration announced agreements with five partners to study the effects of anesthetics and sedatives on the neurocognitive development of infants and young children. The Safety of Key Inhaled and Intravenous Drugs in Pediatrics (SAFEKIDS) Initiative is a multi-year project designed to address major gaps in scientific information about the safe use of anesthetics and sedatives received by millions of children each year.
Related Posts
Tags: academic, clinical, initiative, launches, partners, safekids
This entry was posted on Tuesday, March 17th, 2009 at 10:03 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



